These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2993022)

  • 61. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts.
    Robberecht P; Waelbroeck M; De Neef P; Tastenoy M; Gourlet P; Cogniaux J; Christophe J
    FEBS Lett; 1988 Feb; 228(2):351-5. PubMed ID: 2830146
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophages.
    Chedeville A; Mirossay L; Chastre E; Hurbain-Kosmath I; Lopez M; Gespach C
    FEBS Lett; 1993 Mar; 319(1-2):171-6. PubMed ID: 8384124
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Promotion of differentiation in human colon carcinoma cells by vasoactive intestinal polypeptide.
    Hoosein NM; Black BE; Brattain DE; Brattain MG
    Regul Pept; 1989 Jan; 24(1):15-26. PubMed ID: 2544928
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
    Abello J; Damien C; De Neef P; Tastenoy M; Hooghe R; Robberecht P; Christophe J
    Eur J Biochem; 1989 Aug; 183(2):263-7. PubMed ID: 2547606
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A new neuroregulator: the vasoactive intestinal peptide or VIP.
    Rosselin G; Maletti M; Besson J; Rostène W
    Mol Cell Endocrinol; 1982 Aug; 27(3):243-62. PubMed ID: 6290287
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Actions of a newly isolated intestinal peptide PHI on pancreatic acini.
    Jensen RT; Tatemoto K; Mutt V; Lemp GF; Gardner JD
    Am J Physiol; 1981 Dec; 241(6):G498-502. PubMed ID: 6172986
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
    Laburthe M; Couvineau A; Rouyer-Fessard C
    Mol Pharmacol; 1986 Jan; 29(1):23-7. PubMed ID: 3003561
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
    Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
    J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.
    Martin JM; Darbon H; Luis J; el Battari A; Marvaldi J; Pichon J
    Biochem J; 1988 Mar; 250(3):679-85. PubMed ID: 2839143
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist- and protein kinase C-mediated desensitization and further evidence for receptor internalization.
    Turner JT; Bollinger DW; Toews ML
    J Pharmacol Exp Ther; 1988 Nov; 247(2):417-23. PubMed ID: 2846820
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human colonic adenylate cyclase. Stimulation of enzyme activity by vasoactive intestinal peptide and various prostaglandins via distinct receptor sites.
    Simon B; Kather H
    Digestion; 1980; 20(1):62-7. PubMed ID: 6243592
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors.
    Virgolini I; Yang Q; Li S; Angelberger P; Neuhold N; Niederle B; Scheithauer W; Valent P
    Cancer Res; 1994 Feb; 54(3):690-700. PubMed ID: 7905785
    [TBL] [Abstract][Full Text] [Related]  

  • 73. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).
    Anderson CM; Mendoza ME; Kennedy DJ; Raldua D; Thwaites DT
    Br J Pharmacol; 2003 Feb; 138(4):564-73. PubMed ID: 12598410
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preferential binding of vasoactive intestinal polypeptide to basolateral membrane of rat and rabbit enterocytes.
    Dharmsathaphorn K; Harms V; Yamashiro DJ; Hughes RJ; Binder HJ; Wright EM
    J Clin Invest; 1983 Jan; 71(1):27-35. PubMed ID: 6294141
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor.
    Xia M; Sreedharan SP; Bolin DR; Gaufo GO; Goetzl EJ
    J Pharmacol Exp Ther; 1997 May; 281(2):629-33. PubMed ID: 9152366
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
    Martin JM; Luis J; Marvaldi J; Pichon J; Pic P
    Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver.
    Chastre E; Emami S; Rosselin G; Gespach C
    Endocrinology; 1987 Dec; 121(6):2211-21. PubMed ID: 2824182
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of nuclear receptors for VIP on a human colonic adenocarcinoma cell line.
    Omary MB; Kagnoff MF
    Science; 1987 Dec; 238(4833):1578-81. PubMed ID: 2825352
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Human vasoactive intestinal peptide1 receptors expressed by stable transfectants couple to two distinct signaling pathways.
    Sreedharan SP; Patel DR; Xia M; Ichikawa S; Goetzl EJ
    Biochem Biophys Res Commun; 1994 Aug; 203(1):141-8. PubMed ID: 8074647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.